Key Account Manager

Project 61 expands its Preventive Maintenance initiative through new collaboration with Regeneron's Let's Get Real About Skin Cancer program. Project 61, Inc. Sep 02, 2026, 13:30 ET New collaboration brings non-melanoma skin cancer prevention and early detection education to professional drivers nationwide. CARMEL, Ind., Sept. 2, 2026 /PRNewswire-PRWeb/ - Project 61, the nationwide nonprofit dedicated to improving the health and life expectancy of America's professional truck drivers, is expanding its Preventive Maintenance axle, one of the organization's 5 Axles of Health(TM), through a new collaboration with Regeneron's Let's Get Real About Skin Cancer, an educational program about advanced non-melanoma skin cancer (NMSC) which focuses on prevention and awareness. Preventive Maintenance encourages drivers to approach their personal health with the same mindset they use to care for their trucks: identifying small issues before they become major problems. The initiative promotes routine medical care, recommended health screenings, preventive services, and early detection to help drivers stay healthier throughout their careers. As the first major initiative under this expanded Preventive Maintenance effort, Project 61 and Regeneron will provide educational resources to help drivers better understand the risks of NMSCs like basal cell carcinoma (BCC) and cutaneous squamous cell carcinoma (CSCC) and the importance of protecting their skin from ultraviolet (UV) exposure, recognizing potential warning signs, and incorporating simple preventive habits into their everyday routines. Professional drivers spend thousands of hours each year behind the wheel, often with repeated sun exposure through side windows. Over time, that cumulative exposure can increase the risk of skin damage and skin cancer, making awareness and early detection an important part of long-term driver health. "Preventive maintenance isn't just something drivers do for their equipment. It's something they should do for themselves," said Jeremy Reymer, founder of Project 61. "The healthiest drivers aren't simply reacting to health problems after they happen. They're taking small, consistent steps to prevent them. Expanding this axle allows us to address important health risks, like advanced non-melanoma skin cancer, that often don't receive enough attention but can have a significant impact on a driver's quality of life and longevity." The educational campaign will provide practical, driver-focused information that encourages drivers to: * Understand how occupational sun exposure affects skin health * Use sunscreen and other protective measures during daily driving * Perform regular skin self-checks for new or changing spots * Schedule annual skin examinations as part of preventive healthcare * Recognize the value of early detection The resources are designed specifically for life on the road, offering realistic strategies that fit the schedules and challenges of professional drivers. "This collaboration represents exactly what Preventive Maintenance is all about," said Reymer. "When drivers have access to practical education and understand why prevention matters, they're better equipped to protect their health." Educational content developed through the collaboration will be available through the Project 61 mobile app and digital platform, alongside the organization's growing library of health education built around the 5 Axles of Health(TM) framework. As Project 61 continues to expand its educational offerings, the organization remains committed to helping drivers build healthier habits through practical, evidence-based resources that fit the realities of life on the road. About Project 61 Project 61 is a nationwide nonprofit dedicated to improving the health and longevity of CDL drivers through education, free resources, and community. Built around its 5 Axles of Health(TM)(Fuel, Move, Recharge, Mental Drive, and Preventive Maintenance) Project 61 equips drivers, fleets, and industry partners with practical tools that support healthier careers and longer lives. About Let's Get Real About Skin Cancer Let's Get Real About Skin Cancer is an educational program from Regeneron aimed at raising awareness around advanced NMSCs, specifically BCC and CSCC. The program launched in 2021 and focuses on educating people about the importance of NMSC prevention and early diagnosis. About Regeneron Regeneron is a leading biotechnology company that invents, develops and commercializes life-transforming medicines for people with serious diseases. Founded and led by physician-scientists, its unique ability to repeatedly and consistently translate science into medicine has led to numerous approved treatments and product candidates in development, most of which were homegrown in its laboratories. Regeneron's medicines and pipeline are designed to help patients with eye diseases, allergic and inflammatory diseases, cancer, cardiovascular and metabolic diseases, neurological diseases, hematologic conditions, infectious diseases, and rare diseases. Media Contact SOURCE Project 61, Inc.

SHAREHOLDER ALERT Bernstein Liebhard LLP announces A securities fraud Class Action Lawsuit has been filed against Regeneron Pharmaceuticals, Inc. (REGN). NEW YORK, Sept. 02, 2026 (GLOBE NEWSWIRE) - Bernstein Liebhard LLP announces that a shareholder has filed a securities class action lawsuit on behalf of investors (the "Class") who purchased or acquired the common stock of Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) between August 1, 2025 and May 15, 2026, inclusive. * Do you, or did you, own shares of Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN)? * Did you purchase your shares between August 1, 2025 and May 15, 2026, inclusive? * Did you lose money in your investment in Regeneron Pharmaceuticals, Inc.? What To Do Next: Investors are encouraged to act promptly and submit a form at Regeneron Pharmaceuticals, Inc. Shareholder Class Action Lawsuit or contact Investor Relations Manager Peter Allocco at (212) 951-2030 or [email protected]. If you wish to serve as lead plaintiff for the Class, you must file papers by September 14, 2026. A lead plaintiff is a representative party acting on other class members' behalf in directing the litigation. Your ability to share in any recovery doesn't require that you serve as lead plaintiff. If you choose to take no action, you may remain an absent class member. All representation is on a contingency fee basis. Shareholders pay no fees or expenses. About The Lawsuit: The lawsuit alleges that defendants made materially false and misleading statements and omissions regarding the Company's business operations, growth prospects, and financial stability. As a result of these alleged misrepresentations, Regeneron common stock traded at artificially inflated prices during the Class Period. When the truth was disclosed, investors allegedly suffered significant losses. About Bernstein Liebhard: Since 1993, Bernstein Liebhard LLP has recovered over $3.5 billion for its clients. In addition to representing individual investors, the Firm has been retained by some of the largest public and private pension funds in the country to monitor their assets and pursue litigation on their behalf. As a result of its success litigating hundreds of class actions, the Firm has been named to The National Law Journal's "Plaintiffs' Hot List" thirteen times and listed in The Legal 500 for sixteen consecutive years. ATTORNEY ADVERTISING. (C) 2026 Bernstein Liebhard LLP. The law firm responsible for this advertisement is Bernstein Liebhard LLP, 10 East 40th Street, New York, New York 10016, (212) 779-1414. Prior results do not guarantee or predict a similar outcome with respect to any future matter. Contact Information: Peter Allocco Investor Relations Manager Bernstein Liebhard LLP https://www.bernlieb.com (212) 951-2030 [email protected]